Add Company
Join Now

Bexson Biomedical / Ketamine Reformulation Development Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bexson Biomedical / Ketamine Reformulation Development's estimated annual revenue is currently $4.2M per year.(i)
  • Bexson Biomedical / Ketamine Reformulation Development's estimated revenue per employee is $201,000

Employee Data

  • Bexson Biomedical / Ketamine Reformulation Development has 21 Employees.(i)
  • Bexson Biomedical / Ketamine Reformulation Development grew their employee count by 17% last year.

Bexson Biomedical / Ketamine Reformulation Development's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Sr. VP Drug DeliveryReveal Email/Phone
3
VP QualityReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$102.7M51125%N/AN/A
#2
$0.4M20%N/AN/A
#3
$38.6M1923%N/AN/A
#4
$35M1272%$62.5MN/A
#5
$36.6M18218%N/AN/A
#6
$131.9M656-3%N/AN/A
#7
$133.5M664N/AN/AN/A
#8
$72.8M362-4%N/AN/A
#9
$551.9M1716-2%N/AN/A
#10
$11.7M5812%N/AN/A
Add Company

What Is Bexson Biomedical / Ketamine Reformulation Development?

Bexson Biomedical is developing non-opioid therapies for pain management. Our goal is to provide therapies that provide relief to patients and reduce the rates of opioid addiction.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$4.2M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M210%N/A
#2
$2.2M22-21%N/A
#3
$3.1M22-15%N/A
#4
$3.5M220%N/A
#5
$3M220%$15.8M